Phoenix Rising supports the Millions Missing global day of protest
Phoenix Rising is delighted to support the demands being made in the ME/CFS community’s first-ever global day of protest …
Discuss the article on the Forums.

FDA's Pharmacy Compounding Advisory Committee considering a bulk drug substance used for ME/CFS

Discussion in 'General ME/CFS News' started by mango, Feb 18, 2016.

  1. mango

    mango Senior Member

    Messages:
    895
    Likes:
    4,858
    "On March 8, 2016, the Pharmacy Compounding Advisory Committee will discuss six bulk drug substances nominated for inclusion on the section 503A bulk drug substances list. FDA will discuss the following nominated bulk drug substances: Quinacrine hydrochloride, boswellia, aloe vera 200:1 freeze dried, D-ribose, chondroitin sulfate, and acetyl-L-carnitine. D-ribose has been nominated for inclusion on the list of bulk drug substances for use in compounding for use in the treatment of heart disease and myalgic encephalomyelitis/chronic fatigue syndrome.

    Additional information can be found at the following web link:"

    http://www.fda.gov/AdvisoryCommitte...acyCompoundingAdvisoryCommittee/ucm486094.htm
     
    ScottTriGuy likes this.
  2. *GG*

    *GG* Senior Member

    Messages:
    6,077
    Likes:
    4,665
    Concord, NH
    Wish this was about LDN!

    GG
     
  3. panckage

    panckage Senior Member

    Messages:
    619
    Likes:
    728
    Vancouver, BC
    I'm confused by the wording... Are they talking about using these things as fillers? Or as the primary drug?
     

See more popular forum discussions.

Share This Page